Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of JK08 for unresectable locally advanced or metastatic cancer conducted by Salubris Biotherapeutics is cur…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance [Phase 2]
A Phase 2 trial is evaluating maintenance therapy with a third-generation EGFR-TKI plus Anlotinib for non-small cell lung cancer with small …
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating DS-3201b in combination with irinotecan for recurrent small cell lung cancer has been terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors [Phase 1, Phase 2]
Phase I/II trial evaluating the safety and preliminary activity of nivolumab combined with vorolanib in patients with refractory thoracic tu…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 [Phase 1]
Phase 1 clinical trial evaluating the GD2-SADA:177Lu-DOTA complex in GD2-expressing solid tumors is currently recruiting, including small ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer [Phase 2]
Phase II study evaluating Ivonescimab in combination with Cadonilimab and chemotherapy for extensive-stage small cell lung cancer; the trial…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Ongoing clinical trial investigating PET-guided radiotherapy for small cell lung cancer; currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-09-27Clinical Trial Update: An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer [Phase 1]
An investigational PET/CT imaging tracer, 124I-hJAA-F11, being evaluated for diagnosing lung cancer in a Phase 1 trial has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250) [Phase 2]
A Phase 2 trial evaluating the combination of berzosertib and topotecan in relapsed platinum-resistant small-cell lung cancer has completed,…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer [Phase 2]
A phase 2 trial evaluating docetaxel plus carboplatin as second-line treatment for small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer [Phase 1, Phase 2]
IMP4297 combined with temozolomide was studied in patients with advanced solid tumors and small cell lung cancer in Phase 1/Phase 2 trials, …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial update showing JS-201 in combination with lenvatinib for small-cell lung cancer, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]
Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensi…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy [NA]
Phase II trial to evaluate consolidative thoracic radiotherapy after chemo-immunotherapy in extensive-stage small-cell lung cancer is curren…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer [Phase 1, Phase 2]
An early-phase clinical trial evaluating hypofractionated radiotherapy combined with immunotherapy for limited-stage small-cell lung cancer,…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic [Phase 2]
Phase 2 clinical trial evaluating intrathecal pemetrexed for small-cell lung cancer patients with refractory brain metastases or leptomening…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]
A Phase 1 trial investigating TAS-116 in combination with palbociclib for advanced breast cancer and RB-deficient solid tumors has been with…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy [Phase 2]
Phase 2 trial comparing TAS-102 with topotecan or amrubicin for small cell lung cancer after platinum therapy has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Trial of BMS-986012 in Combination With Platinum and Etoposide [Phase 1]
This document reports the completion of a Phase 1 trial evaluating the investigational antibody BMS-986012 in combination with a platinum ag…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing JK-1201I versus Topotecan in relapsed extensive-stage small cell lung cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating safety, tolerability, and preliminary efficacy of CC-90011 in combination with cisplatin and etoposide as first-l…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
This entry reports on the QUILT-2.013 first-line treatment study for extensive-stage small cell lung cancer (Phase 1/2) sponsored by NantCel…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer [NA]
This completed clinical trial evaluates hypofractionated radiotherapy for limited-stage small cell lung cancer, reporting on safety and effi…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial update reporting results for durvalumab in combination with platinum and etoposide as first-line therapy for extensive-stage s…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial is recruiting to evaluate Adebrelimab in combination with chemotherapy and concurrent SBRT as neoadjuvant treatment for limite…